medigraphic.com
ISSN 1995-9427 (Print)

2022, Number 1

<< Back Next >>

Invest Medicoquir 2022; 14 (1)

Bacterial and fungal co-infection in individuals with covid - 19

Aguilera CY, Díaz MY, Pérez BE, Pérez MJM, Morales RB

Language: Spanish
References: 14
Page: 1-12
PDF size: 152.05 Kb.


ABSTRACT

Introduction. The probability coexists that patients with severe COVID-19 may subsequently or coincidentally become infected by bacteria or fungi. Methods. A descriptive study was carried out in the period from January to March 2021, at the Manuel Fajardo hospital, Villa Clara Province, Cuba. The study population consisted of 815 patients who remained admitted to that hospital with a confirmed diagnosis for the real-time polymerase chain reaction test for SARS-CoV-2. The study variables were: age, sex, months of the year, coinfection, state at discharge, isolated microorganisms and antimicrobial susceptibility. Results. 2, 7 % of the patients had an associated infection. 1, 9 % died and the majority of deaths occurred in the months of March and April. Among the deceased, 68, 8 % had an associated infection. Complot Acinetobacter baumannii calcoaceticus was the most isolated microorganism. Conclusions. Clinical data on bacterial and fungal infections are invaluable to guide evidence-based treatment of COVID-19. Therefore, a diagnostic protocol is required to determine bacterial and fungal associated infection in SARS-CoV-2.


REFERENCES

  1. Nebreda-Mayoral T, Miguel-Gómez MA, March-Rosselló GA, Puente-Fuertes LE, Cantón-Benito E, Martínez-García AM, et al. Infección bacteriana/fúngica en pacientes con COVID-19 ingresada en un hospital de tercer nivel de Castilla y León, España. Enfermedades Infecciosas y Microbiología Clínica,2020, [acceso: 10/02/2021];79(8): 70–76. Disponible en: http://www.sciencedirect.com/science/article/pii/S0213005X20304043

  2. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 [acceso: 10/08/2020]; 579(7798): 270–273. Disponible en: https://doi.org/10.1038/s41586-020-2012-7https://www.nature.com/articles/s41586-020-2012-7

  3. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020[acceso: 20/08/2020]. [aprox. 10 pant.]. Disponible en: http://scholar.google.com/scholar_url?url=https://jamanetwork.com/journals/jama/articlepdf/2764787/jama_kim_2020_ld_200032.pdf&hl=es&sa=T&oi=ucasa&ct=ufr&ei=Y9jCXqTAHPiLy9YP8KehmAo&scisig=AAGBfm2hiKsZ6FMpE4himcrxSVDe56yXmA&nossl=1

  4. González Castro A, Escudero Acha P, Peñasco Y, Leizaola A, Martínez de Pinillos Sánchez V, García de Lorenzo A. Cuidados intensivos durante la epidemia de coronavirus 2019. Medicina Intensiva. 2020. [acceso: 22/08/2020] .Disponible en: https://www.sciencedirect.com/science/article/pii/S0210569120300899

  5. Bengoechea JA, Bamford C GG. SARS‐CoV‐2, bacterial co‐infections, and AMR: the deadly trio in COVID‐19.EMBO Mol Med. [acceso: 23/05/2021]12(7). [aprox. 10 pant.].Disponible en: https://www.embopress.org/doi/pdf/10.15252/emmm.202012560

  6. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020 May 2 [acceso: 26/07/2020]; 0954162(478):1–4. Disponible en: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa530/5828058

  7. Kirchhelle C, Roberts A, Singer AC. Antibiotic Resistance Could Lead to More COVID-19 Deaths. Scientific American. 2020 April [acceso: 23/08/2020],2(2). [aprox. 10 pant.].Disponible en:https://blogs.scientificamerican.com/observations/antibiotic-resistance-could-lead-to-more-covid-19-deaths/

  8. Zhou P, Liu Z, Chen Y, Xiao Y, Huang X, Fan X. Bacterial and fungal infections in COVID-19 patients: A matter of concern. Infection Control & Hospital Epidemiology.2020 [acceso: 20/05/2021]: 1–2. Disponible en: https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/bacterial-and-fungal-infections-in-covid19-patients-a-matter-of-concern/2835D28A101A8FFAA9A9F4FF8FC4469F/core-reader

  9. Rothe K, Feihl S, Schneider J, Wallnöfer F, Wurst M, Lukas M. et al. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. European Journal of Clinical Microbiology & Infectious Diseases,2021 [acceso: 20/05/2021]; 40(4): 859-869. Disponible en: https://link.springer.com/article/10.1007/s10096-020-04063-8

  10. Aguilera Calzadilla Y, Díaz Morales Y, Ortiz Díaz LA, Gonzalez Martínez OL, Lovelle Enríquez OA, Sánchez Álvarez ML. Infecciones bacterianas asociadas a la COVID-19 en pacientes de una unidad de cuidados intensivos. Revista Cubana de Medicina Militar .2020[acceso: 26/03/2021] 49(3): e0200793. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/793/539

  11. Cultrera R, Barozzi A, Libanore M, Marangoni E, Pora R, Quarta B, et al. Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings. Int J Environ Res Public Health. 2021 [acceso: 26/03/2021] 18(8):4358. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073702/

  12. Aguilera Calzadilla Y, Díaz Morales Y, Guerra Martínez M, Sánchez Álvarez ML, Martínez Frometa M. Aislamientos de Acinetobacter spp. en infecciones asociadas a la asistencia sanitaria. Revista Cubana de Medicina Militar .2019[acceso: 26/03/2021]; 48(3): 505-518. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/335/358

  13. Ramos Suzarte M, Díaz Y, Martin Y, Calderón NA, Santiago W, Viñet O et al. Use of a humanized anti-CD6 monoclonal antibody (itolizumab) in elderly patients with moderate COVID-19. medRxiv 2020.07.24.20153833[acceso: 26/03/2021]. Disponible en: https://doi.org/10.1101/2020.07.24.20153833

  14. Bello R, García Lorenzo MM, Ramón-Hernández A, Bello-Garcia B, Bello-Garcia M, Caballero Y, Madera-Quintana J.et al. Una mirada a la inteligencia artificial frente a la COVID-19 en Cuba. Rev. Cub. Transf. Dig. 2020 [citado 2 de marzo de 2021];1(3):27-36. Disponible en: https://rctd.uic.cu/rctd/article/view/92




2020     |     www.medigraphic.com